CROss Alliance® is the commercial brand name for CROSS Research SA, a private Swiss Contract Research Organization (CRO) active in the field of clinical drug development.

CROSS Research operates in full compliance with Good Clinical Practice (ICH-GCP R2). ICH-GCP is directly anchored in the Swiss legislation and, since 2014, the Swiss Competent Surveillance Authority for Medicines and Medical Devices (Swissmedic) is a full member of ICH.

CROSS Research is:

  • a GCP Training Provider at Investigator level officially recognised by Swissethics;
  • a Gold Member of the Clinical Data Interchange Standards Consortium Inc. (CDISC), since 2012.

Since 2001 the quality and compliance of CROSS Research has been constantly monitored by frequent study and system inspections of different Competent Authorities (Switzerland, Austria, Spain, US), by the local Authorities (Canton Ticino) as well as by frequent Clients’ Audits.

Most recent Competent Authorities (CA) inspections at CROSS Research phase I unit:

  • 2014 FDA, US CA
  • 2015 Swissmedic, Swiss CA
  • 2021 Swissmedic, Swiss CA

Last few years clients’ audits: